Organization (Industry)
Torrent Pharma (India)
ClinicalTrials.gov lists Torrent Pharma (India) as lead sponsor of 72 trials. It has 8 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Torrent Pharma (India): 72 lead-sponsored trials and 1 legal-entity registration.
Disease areas (8)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Acne Vulgaris | 1 |
| Dyslipidemias | 1 |
| Hypertension | 1 |
Showing 5 of 8 disease areas.
Trials by start year as sponsor or collaborator (9)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2021 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2013 | 2 |
| 2011 | 8 |
| 2010 | 2 |
| 2009 | 2 |
| 2007 | 2 |
| 2005 | 1 |
Recruitment duration, a model prediction: none of the 72 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (8)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| METFORMIN | 6 |
| Citalopram | 2 |
| Topiramate | 2 |
| Amlodipine 5 MG | 2 |
| Risperidone | 2 |
Showing 5 of 8 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 2 hit target (n=2) | 1 of 1 on time (n=1) |
Journals published in (3)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Diabetes, metabolic syndrome and obesity : targets and therapy | 1 |
| FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 1 |
| PloS one | 1 |
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 47 | 3 | 2023-01-24 |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 24 |
FDA recalls (85)
Shown in this order: most recent first.
| Product | Classification | Initiated |
|---|---|---|
| Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-30 | Class II | 2025-05-27 |
| Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister) | Class II | 2025-05-27 |
| Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., Levittown, PA 19057, NDC# 13668-096-90. | Class II | 2022-04-11 |
| Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: Torrent Pharmaceuticals Ltd. Bharuch-392130, India Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. | Class II | 2021-12-02 |
| Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30 | Class III | 2021-12-01 |
Showing 5 of 85 recalls.
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 201 | 2026-08-13 |
Manufacturing and distribution sites (8)
Shown in this order: severity rank then name.
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| Torrent Pharmaceuticals Limited | Indrad, IN | FDA | |
| Torrent Pharmaceuticals Limited | Pithampur, IN | EMA, FDA, Health Canada | |
| Torrent Pharmaceuticals Limited | Gandhinagar, IN | EMA, FDA, Health Canada | |
| Torrent Pharmaceuticals Limited | Bharuch, IN | EMA, FDA, Health Canada | |
| Torrent Pharmaceuticals Limited | Visakhapatnam, IN | FDA |
Showing 5 of 8 sites.
Organization relationships (1)
| Related organization | Relationship | Evidence |
|---|---|---|
| Iqvia Holdings Inc. | Uses vendor | 1 |
Latest dated events (377)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-08-13 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2026-08-13 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2026-08-07 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2026-08-03 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2026-07-24 | FDA import refusal | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
Showing 5 of 377 events.
Biomarker capability evidence (20)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| NPPB | Trial sponsor | Named in trial inclusion criteria |
| NR3C2 | Trial sponsor | Named in trial inclusion criteria |
| TNF | Trial sponsor | Named in trial inclusion criteria |
| ATP12A | Trial sponsor | Named in trial exclusion criteria |
| ATP12A | Trial sponsor | Named in trial exclusion criteria |
Showing 5 of 20 evidence rows.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.